8-K
Current Report
Solid Biosciences Inc. Filed Acc 0001193125-20-004274
Exit or restructuring costs · Executive or director change · Other events
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d845963d8k.htm…